ClinicalTrials.Veeva

Menu
E

Evolution Research Group | Woodland Research Northwest

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SEP-363856
Edaravone
Rapastinel
Azetukalner
MK-8189
Cariprazine
Brexpiprazole
KarXT
Glucose
Risperidone

Parent organization

This site is a part of Evolution Research Group

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

12 of 78 total trials

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression) (X-CEED)

X-CEED is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of azetukalner in adult part...

Active, not recruiting
Bipolar II Disorder
Bipolar I Disorder
Drug: Placebo
Drug: Azetukalner

This study evaluates the efficacy and safety of brenipatide when compared to placebo for reducing the risk of relapse to cigarette smoking in adults...

Enrolling
Smoking
Drug: Placebo
Drug: Brenipatide
Status recently updated

The main purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight with or without Type...

Not yet enrolling
Enrolling
Overweight
Obesity
Drug: LY4167586
Drug: Placebo
Locations recently updated

This is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mania with mixed features in Bipo...

Enrolling
Bipolar Disorder Type I With Mania
Drug: Valproate
Drug: Lamotrigine
Status recently updated

A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder

Not yet enrolling
Enrolling
Major Depressive Disorder
Drug: Placebo
Drug: BMS-986511

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, inpatient study in participants with bipolar disorder experiencing an a...

Enrolling
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Drug: KarXT
Other: Placebo

Evaluate the efficacy and safety of Ulotaront (SEP-363856) in acutely psychotic subjects with schizophrenia

Active, not recruiting
Schizophrenia
Drug: SEP-363856
Other: Placebo

X-CEED-OLE is a Phase 3, multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner in adult participa...

Active, not recruiting
Bipolar II Disorder
Bipolar I Disorder
Drug: Azetukalner

X-NOVA-OLE is a multicenter, open-label study to evaluate the long-term safety, tolerability, and efficacy of azetukalner as a monotherapy in adult p...

Active, not recruiting
Major Depressive Disorder
Drug: Azetukalner

This study will evaluate the efficacy and safety of SPN-821 in adults with major depressive disorder

Enrolling
Major Depressive Disorder (MDD)
Drug: Placebo
Drug: SPN-821 2400 mg

This study is a randomized, double-blind, placebo and active-controlled, multicenter trial conducted to evaluate whether PP-01 mitigates the withdraw...

Enrolling
Cannabis Withdrawal
Combination Product: PP-01
Drug: Nabilone

This is a multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of ITI-1284 as monotherapy...

Enrolling
Generalized Anxiety Disorder
Drug: Placebo
Drug: ITI-1284 10 mg

Trial sponsors

Otsuka logo
AbbVie logo
Allergan logo
Jazz Pharmaceuticals logo
Merck Sharp & Dohme (MSD) logo
Shionogi logo
X
Bristol-Myers Squibb (BMS) logo
Janssen (J&J Innovative Medicine) logo
R

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems